Latest California Healthline Stories
Hospitals And Surgery Centers Play Tug-Of-War Over America’s Ailing Knees
As Medicare considers paying for knee replacement procedures outside the hospital, doctors debate patient choice and the potential for post-operation complications.
Latest Hospital Injury Penalties Include Crackdown On Antibiotic Resistant Germs
Medicare reduced payments to 769 hospitals in the program, punishing facilities that have high rates of patient injuries, including infections, blood clots, falls and bed sores. This year, federal officials also added the prevalence of two dangerous bacteria.
Grilled About Deadly Superbug Outbreaks, Execs At Scope Maker Olympus Take Fifth
Lawyers who deposed top company officials in a civil case say they declined to answer questions about their failure to warn American hospitals of infection risks. Industry giant Olympus also is the subject of a criminal probe.
The Throwaway Scope: A Way To Ditch Superbugs?
Small manufacturers are betting that disposable medical scopes will slash the risk of infection during procedures. Some doctors are skeptical of the cheaper models.
Without ACA Guarantees, 52 Million Adults Could Have Trouble Buying Individual Plans
More than a quarter of adults under the age of 65 have health problems that could lead to a denial of insurance if they were on the individual market and the health law’s protections were revoked under the overhaul planned by Republicans, according to research by the Kaiser Family Foundation.
Insurers’ Flawed Directories Leave Patients Scrambling For In-Network Doctors
Many consumers find that doctors listed in their plan’s directories aren’t accepting new patients, charge large concierge fees or may not even be in the network. Regulators don’t check.
Price Poised To Protect Doctors’ Interests At HHS
As a Republican congressman, orthopedic surgeon Tom Price introduced bills to protect doctors’ financial interests.
A Frenzy Of Lobbying On 21st Century Cures
Three lobbyists for every member of Congress in a push to pass a bill that increases research funding and speeds up approvals.
Long-Stalled FDA Reform Sits On Senate’s Lame-Duck Calendar
The legislation would give federal officials more flexibility in evaluating the effectiveness and safety of drugs and devices and add billions of dollars to NIH funding. But critics say it could endanger patients’ safety and doesn’t do enough to stop spiraling drug prices.
Study Finds Nearby Retail Clinics Don’t Drive Down ER Visits
The results suggest that retail clinics may not provide a solution for reducing unnecessary emergency department visits, researchers say.